References
- MazziottiGBilezikianJCanalisECocchiDGiustinaANew understanding and treatments for osteoporosisEndocrine201241586922180055
- CavalliLBrandiMLTargeted approaches in the treatment of osteoporosis: differential mechanism of action of denosumab and clinical utilityTher Clin Risk Manag2012825326622745560
- AnastasilakisADToulisKAPolyzosSAAnastasilakisCDMakrasPLong-term treatment of osteoporosis: safety and efficacy appraisal of denosumabTher Clin Risk Manag2012829530622767993
- IwamotoJSatoYUzawaMMatsumotoHFive-year follow-up of a woman with pregnancy and lactation-associated osteoporosis and vertebral fracturesTher Clin Risk Manag2012819519922547939
- WellsGACranneyAPetersonJAlendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal womenCochrane Database Syst Rev20081CD00115518253985
- IwamotoJTakadaTSatoYMatsumotoHInfluence of treatment with alendronate on the speed of sound, an ultrasound parameter, of the calcaneus in postmenopausal Japanese women with osteoporosis: a clinical practice-based observational studyTher Clin Risk Manag2012828729322767992